Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
124 Leser
Artikel bewerten:
(0)

New World Medical Introduces the Ahmed ClearPath ST Glaucoma Drainage Device

The Ahmed ClearPath® ST addresses market demands by expanding the trusted Ahmed ClearPath® brand to now feature a smaller tube lumen.

RANCHO CUCAMONGA, CA / ACCESS Newswire / September 2, 2025 / New World Medical, a leading innovator in ophthalmic surgical devices, proudly announces the launch of the Ahmed ClearPath® ST, a non-valved glaucoma drainage device. Building on the success of the Ahmed ClearPath®, the new model introduces key differences designed to provide surgeons more options to fit their patient's needs. A distinguishing feature of the Ahmed ClearPath® STis its smaller tube lumen, that also includes a pre-threaded 6-0 Prolene ripcord suture and a 25-gauge needle for the scleral tunneling.

"The Ahmed ClearPath® ST represents a significant step forward, allowing glaucoma specialists to overcome long-standing limitations associated with traditional tube shunts. The smaller diameter tube enables excellent pressure control with the potential for enhanced safety and improved postoperative management and personalization of treatment," said Dr. Manjool Shah.

Flexibility to Fit Every Patient's Needs

The Ahmed ClearPath® brand offers flexibility to fit every patient's needs by offering two plate sizes and two tube sizes, providing four options within one brand. The plate sizes, 250mm2 and 350mm2, allow surgeons to choose between a true single-quadrant implant or a larger implant based on surgeon preference and patient's needs. The Ahmed ClearPath® features a tube with an inner diameter of 305 µm and an outer diameter of 635 µm, while the new Ahmed ClearPath® ST offers a smaller profile tube with a 127 µm inner diameter and a 457 µm outer diameter, providing surgeons with flexibility based on patient needs and surgical preferences.

Why Ahmed ClearPath® ST?

Optimized Plate Design: The 250 model allows for a true single-quadrant implantation and avoids rectus muscle isolation. The 350 model features a winged design to avoid rectus muscle attachment points.

Anterior Fixation Eyelets: Designed for easier suture access and a more posterior plate placement.

Globe-Conforming Flexible Material: Allows the globe-shaped implant to provide a more natural fit, while providing a low-lying, diffuse bleb.

All-Inclusive Packaging: Includes a pre-threaded 6-0 Prolene ripcord and a 25G needle for scleral tunneling.

New World Medical Innovation

The Ahmed ClearPath® ST is one of several exciting New World Medical launches this year. Other innovations include the VIA360 Surgical System and the enhanced STREAMLINE® Surgical System featuring a clear tip. "New World Medical is committed to continuous innovation. The Ahmed ClearPath® ST marks another milestone in our mission to deliver innovative solutions that empower surgeons and improve the lives of patients globally," says Raymond Kong, Chief Commercial Officer at New World Medical.

About New World Medical

New World Medical was founded by Dr. A. Mateen Ahmed, with a mission to benefit humanity. New World Medical pursues this purpose by developing and manufacturing innovative surgical devices that provide vision-preserving treatments for patients with glaucoma.

New World Medical's product portfolio includes its flagship devices: the market-leading glaucoma drainage device the Ahmed® Glaucoma Valve, the Ahmed ClearPath®, the KDB GLIDE®; the STREAMLINE® Surgical System; the VIA360 Surgical System; and the newest member of its innovative portfolio the Ahmed ClearPath® ST.

To learn more about the unique mission of New World Medical or its innovative product line, please visit https://www.newworldmedical.com.

Contact Information

Raymond Kong
Chief Commercial Officer
rkong@newworldmedical.com

.

SOURCE: New World Medical



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/new-world-medical-introduces-the-ahmed-clearpathr-st-glaucoma-drainag-1067625

© 2025 ACCESS Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.